{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-004780","form_type":"8-K","ticker":"BBNX","cik":"0001674632","company_name":"Beta Bionics, Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.611117+00:00","generated_at":"2026-05-17T23:44:08.976962+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Beta Bionics Q2 net sales up 54% to $23.2M; raises full-year guidance","bullets":["Net sales $23.2M (+54% YoY); DME channel $18.6M (+31%), PBP channel $4.6M (+498%).","Installed base 24,085 users (+200%); new patient starts 4,934 (+57%), 71% from MDI.","Net loss $16.9M (negative 73% of sales) vs $14.5M (negative 96%) in Q2 2024.","Adjusted EBITDA -$14.5M (negative 63% of sales) vs -$10.0M (negative 66%).","Cash and investments $280.9M as of June 30; raised full-year 2025 revenue and adjusted EBITDA guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-004780","json":"https://secwatch.observer/filing/0001171843-25-004780.json","markdown":"https://secwatch.observer/filing/0001171843-25-004780.md","text":"https://secwatch.observer/filing/0001171843-25-004780.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325004780/0001171843-25-004780-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674632/000117184325004780/f8k_072925.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:44:08.976962+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}